Share your thoughts about the Research Communities in our survey.

Preliminary Phase 2a Readout for a Novel Drug Discovered and Designed Using Generative AI Sets a Major Milestone in AI-Powered Drug Discovery

Insilico Medicine’s AI-Designed Small Molecule Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis Yields Positive, Promising Phase 2 Trial Data

Alex Zhavoronkov, PhD and 1 other

Sep 23, 2024

Generative Artificial Intelligence for Drug Discovery: How the First AI-Discovered and AI-designed Drug Progressed to Phase 2 Clinical Testing

Nature Biotechnology

Behind the Paper

Generative Artificial Intelligence for Drug Discovery: How the First AI-Discovered and AI-designed Drug Progressed to Phase 2 Clinical Testing

Frank Pun and 2 others

Mar 14, 2024

Cookies

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website. You can decide for yourself which categories you want to deny or allow. Please note that based on your settings not all functionalities of the site are available.

Further information can be found in our privacy policy.

Fadi Pulous

Preliminary Phase 2a Readout for a Novel Drug Discovered and Designed Using Generative AI Sets a Major Milestone in AI-Powered Drug Discovery

Generative Artificial Intelligence for Drug Discovery: How the First AI-Discovered and AI-designed Drug Progressed to Phase 2 Clinical Testing

Cookies